Immix Biopharma, Inc. IMMX Change in Other Assets
Change in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Immix Biopharma, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.
The official record: Immix Biopharma, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immix Biopharma, Inc.'s change in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immix Biopharma, Inc.'s change in other assets?
- Immix Biopharma, Inc. (IMMX) reported change in other assets of $866.6K in Q1 2026.
- How has Immix Biopharma, Inc.'s change in other assets changed year-over-year?
- Immix Biopharma, Inc.'s change in other assets increased by 173.7% year-over-year, from $316.62K to $866.6K.
- What is the long-term trend for Immix Biopharma, Inc.'s change in other assets?
- Over 2 years (2021 to 2024), Immix Biopharma, Inc.'s change in other assets has grown at a 5.0% compound annual growth rate (CAGR), from $502.8K to -$554.77K.
- What does change in other assets mean?
- Change in miscellaneous assets affecting operating cash flow.